CAV1 and breast cancer: Intriguingly, Cav-1 silencing not only suppressed the migratory-stimulating effect of hypoxia but also enhanced the ability of SA in suppressing metastasis, indicating that Cav-1 may act as the main pharmaceutical target of SA in suppressing breast cancer metastasis under hypoxic stress (Figures 7D,E).